Vaccine Therapy in Treating Patients With Recurrent Glioblastoma

Clinical trial NCT03360708 · COMPLETED

Trial details

NCT number: NCT03360708
Sponsor: Mayo Clinic
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Giant Cell Glioblastoma Recurrent Glioblastoma Recurrent Gliosarcoma

Start date: 2013-11-27
Primary completion: 2021-06-02
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.